1. Home
  2. PRME vs SVCC Comparison

PRME vs SVCC Comparison

Compare PRME & SVCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • SVCC
  • Stock Information
  • Founded
  • PRME 2019
  • SVCC 2024
  • Country
  • PRME United States
  • SVCC United States
  • Employees
  • PRME N/A
  • SVCC N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • SVCC
  • Sector
  • PRME Health Care
  • SVCC
  • Exchange
  • PRME Nasdaq
  • SVCC Nasdaq
  • Market Cap
  • PRME 191.7M
  • SVCC 218.3M
  • IPO Year
  • PRME 2022
  • SVCC 2025
  • Fundamental
  • Price
  • PRME $2.71
  • SVCC $10.22
  • Analyst Decision
  • PRME Buy
  • SVCC
  • Analyst Count
  • PRME 6
  • SVCC 0
  • Target Price
  • PRME $9.38
  • SVCC N/A
  • AVG Volume (30 Days)
  • PRME 3.3M
  • SVCC 19.6K
  • Earning Date
  • PRME 08-04-2025
  • SVCC 01-01-0001
  • Dividend Yield
  • PRME N/A
  • SVCC N/A
  • EPS Growth
  • PRME N/A
  • SVCC N/A
  • EPS
  • PRME N/A
  • SVCC N/A
  • Revenue
  • PRME $3,846,000.00
  • SVCC N/A
  • Revenue This Year
  • PRME $104.12
  • SVCC N/A
  • Revenue Next Year
  • PRME $196.78
  • SVCC N/A
  • P/E Ratio
  • PRME N/A
  • SVCC N/A
  • Revenue Growth
  • PRME 550.76
  • SVCC N/A
  • 52 Week Low
  • PRME $1.11
  • SVCC $9.95
  • 52 Week High
  • PRME $6.75
  • SVCC $10.31
  • Technical
  • Relative Strength Index (RSI)
  • PRME 69.76
  • SVCC N/A
  • Support Level
  • PRME $1.56
  • SVCC N/A
  • Resistance Level
  • PRME $2.78
  • SVCC N/A
  • Average True Range (ATR)
  • PRME 0.26
  • SVCC 0.00
  • MACD
  • PRME 0.08
  • SVCC 0.00
  • Stochastic Oscillator
  • PRME 76.81
  • SVCC 0.00

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About SVCC Stellar V Capital Corp. Class A Ordinary Shares

Stellar V Capital Corp is a blank check company.

Share on Social Networks: